Ads
related to: regeneron- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Sign Up
Sign Up for Updates, News
and Much More.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
Search results
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 5 hours agoOver the past year, many Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold a significant...
Why Regeneron (REGN) Could Beat Earnings Estimates Again
Zacks via Yahoo Finance· 3 days agoRegeneron (REGN) has an impressive earnings surprise history and currently possesses the right...
Regeneron Pharmaceuticals’ (REGN) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 2 days agoCantor Fitzgerald reaffirmed their neutral rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a research note released on Monday morning, Benzinga ...
Regeneron commits $500M to new venture capital fund
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: Regeneron Pharmaceuticals is getting into biotechnology investing, committing $500 million over the next five years to an independent venture...
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
FierceBiotech· 4 days agoRegeneron is joining its pharma peers in the venture investing sector, committing up to $500 million...
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Zacks via Yahoo Finance· 1 day agoIt was a busy week in the biotech sector with lots of important regulatory and pipeline updates....
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals,...
Morningstar· 22 hours agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron ...
Bank of America Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $720.00
ETF DAILY NEWS· 5 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price lifted by Bank of America from $710.00 to $720.00 in a research note published on Friday morning ...
Cathie Wood's ARK buys its Bitcoin and Ethereum ETFs, and more Tesla stock By Investing.com
Investing.com· 8 hours agoCathie Wood's ARK buys its Bitcoin and Ethereum ETFs, and more Tesla stock
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Reduced by Sandy Spring Bank
ETF DAILY NEWS· 6 days agoSandy Spring Bank cut its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 73.3% during the fourth quarter, HoldingsChannel.com reports. The ...